Compound ID | 128
Synonym(s): CEM-10 in USA
Class: Fusidane
| Spectrum of activity: | Gram-positive |
| Details of activity: | Prosthetic joint infections, acute bacterial skin and skin structure infections (ABSSSI) |
| Institute where first reported: | Laboratories of Leo Pharmaceutical Products, Copenhagen, Denmark; Cempra Inc.,USA |
| Year first mentioned: | 2010 |
| Highest developmental phase: | Phase 3 |
| Development status: | Approved in Europe, off-patent |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3000226 |
| Guide to Pharmacology: | fusidic acid |
| Citations: |
|
| Patent: | US8247394B2 |